using dexmedetomidine as the main agent for anesthetic management during radiosurgery in a child
Clicks: 351
ID: 133367
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
351 views
44 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #1 of 6 articles by views in journal of public health management and practice
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This clinical case demonstrates specific features of anesthetic management during radiosurgery in pediatric patients considering the limited access to them during continuous manipulations with pharmacological sedation. Considering the age of the child, dexmedetomidine, the drug from the group of agonists of α2-adrenergic receptors, was used as the main agent. It was used since it could be administred by the noninvasive way for premedication and intravenously in a form of infusion to provide the necessary depth of sedation with preservation of spontaneous breathing and minimization of uncontrolled motions of the patient.
| Reference Key |
refiev2019using
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;A. M. Аrefiev;A. Yu. Lubnin;A. S. Kulikov |
| Journal | journal of public health management and practice |
| Year | 2019 |
| DOI |
10.21292/2078-5658-2018-15-6-69-73
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.